Alkaline Phosphatase Kits Market Indicates Notable CAGR growth by 2027

Posted by Arslan on February 27th, 2019

In order to study the many forthcoming movements and patterns prevailing in the global market, FactMR has included the latest Forecast report on Alkaline Phosphatase Kits Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Alkaline Phosphatase Kits Market forthcoming trends by 2027, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2027.

Recent studies have linked an array of inter-abdominal diseases with the use of raw milk and its products. Regulatory authorities around the world are recommending use of pasteurized milk and its products over raw milk. According to multiple researches, raw milk has been found to carry dangerous pathogens such as E.Coli, Listeria, Campylobacter, and Listeria, which are known for causing serious health issues.

Rising awareness about these concerns is influencing consumers to opt for pasteurized milk. With ‘mindful choices’ trend driving the food and beverages industry, consumers are becoming more particular about the ingredients used in products they consume. The aforementioned factors have boosted the adoption of alkaline phosphatase kits to ensure the milk used in the production of dairy products meets the standards expected by consumers.

Alkaline phosphatase kits easy to use, accurate, and less time-consuming – these features have led to their widespread adoption across a range of industries. The effectiveness of alkaline phosphatase kit aids companies in adhering to the standards of dairy production. These broader factors are likely to provide an impetus to alkaline phosphatase market in the future.  

Growing Adoption in Healthcare Diagnostics Creating Opportunities

The level of alkaline phosphates in human serums and other bodily fluids are indicative of a variety of complications that may arise in the body. Higher levels of alkaline phosphatase levels are linked to problems related to liver, gallbladder, pancreas, intestine, or other serious infections. The level of alkaline phosphatase in a patient’s blood helps doctors identify conditions like hepatitis, cirrhosis, cholecystitis, and blockage of bile ducts. Alkaline phosphatase levels are also indicative of liver and bile ducts cancer. Alkaline phosphatase kits play a pivotal role in the detection of disorders and paving the pathway for the further treatment required in each case. The growing use of alkaline phosphatase kits in healthcare diagnostics is likely to create significant opportunities for stakeholders during the course of the forecast period.

The relative affordability of alkaline phosphate kits with pack sizes ranging from 101 to 500 have made it the most preferred choice among end-users. The significant price difference between pack sizes of over 500 and kits with sizes ranging from 101 to 500 makes the latter an affordable choice. Further, the reagents used in the alkaline phosphatase kit are stable for a year when stored in conditions as directed by the manufacturers and need to be replaced annually. Due to this reason, numerous companies are benefitting from the utility offered by alkaline phosphatase kits with pack sizes ranging from 101-500. The companies have been able to maintain the optimal balance between demand and supply while using kits with the aforementioned pack sizes which has led to its widespread acceptance in the market.     

Unreliability of Alkaline Phosphatase Kit Results Remains a Challenge to Wider Adoption

Although alkaline phosphatase kit is an efficient way of detecting higher or lower levels of alkaline phosphatase in the blood, it is not necessarily indicative of an abnormality in the body. Sometimes, during pregnancy, alkaline phosphatase levels may rise due to the placental influx. Also, higher levels of alkaline phosphatase are observed during bone formation and development. Due to the likelihood of the kit providing false positives, it is used in tandem with other diagnostic tests to determine the cause, severity, and prognosis of an underlying disease.  

US Continues to Spearhead the Alkaline Phosphatase Kits Market

North America remains the largest market for alkaline phosphatase kits, on account of robust demand in the US. The US accounts for the largest revenue share, not only in North America but globally as well. A notable reason for US holding the majority market share is the high preference for pasteurized milk in the region. According to a mandate issued by the Food and Drug Association (FDA) in 1987, the use of raw milk for the production of milk and other dairy products was banned.